Foot ischaemia and toe skin necrosis associated with interleukin-2 infusion in an HIV-infected patient.

Full Abstract

A 39-year-old white man developed a severe left toe foot ischaemia and toe skin necrosis following his 12 courses of interleukin (IL)-2 (4.5 MIU twice a day, subcutaneously) for five days every two months. He had no known general risk factors for thrombosis other than HIV infection. An arterial Doppler ultrasound examination of the leg confirmed the permeability of the posterior tibial artery and its digital pulse. A diagnosis of foot ischaemia and toe skin necrosis was made. The suspected causative agent was IL-2 since this was the only drug that the patient was taking before the symptoms appeared. The patient was empirically treated with an aspirin and pentoxifylline in order to improve local microcirculation. We observed a satisfactory response with a quick resolve of skin lesions. The most possible cause of foot ischaemia and toe skin necrosis was considered to be IL-2 because of the temporal relationship between the exposure to the drug and onset of symptoms. Based on the Naranjo probability scale, IL-2 could be considered the probable cause of the foot ischaemia and toe skin necrosis. If clinical evaluation leads to the suspicion of ischaemic process, therapy with IL-2 should be discontinued immediately.

Author information

Author/s: Belda, A (A); Borrás-Blasco, J (J); Lopez-Montes, L (L); Rosique-Robles, D (D); Casterá, E (E); Abad, J (J);

Affiliation: Internal Medicine Service, Hospital de Sagunto, Spain.

Journal and publication information

Publication Type: Case Reports; Journal Article

Journal: International journal of STD & AIDS (Int J STD AIDS), published in England. (Language: eng)

Reference: 2009-Aug; vol 20 (issue 8) : pp 577-9

Dates: Created 2009/07/23; Completed 2009/11/03;

PMID: 19625594, status: MEDLINE (last retrieval date: 11/3/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.